OMNICELL, INC. — Director's Dealing 2019

Mar 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2019-03-11

Reporting Person: Seim Robin Gene (President, Global A & M A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-11	Common Stock	M	28800	—	Acquired	93418	Direct
2019-03-11	Common Stock	S	7296	$83.6989	Disposed	86122	Direct
2019-03-11	Common Stock	S	21504	$83.6989	Disposed	64618	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-11	Stock Options NQ (Right to Buy)	$44.25	M	13849	Disposed	2028-02-05	Common Stock (13849)	Direct
2019-03-11	Stock Options NQ (Right to Buy)	$36.70	M	7165	Disposed	2028-02-07	Common Stock (7165)	Direct
2019-03-11	Stock Options NQ (Right to Buy)	$27.70	M	5442	Disposed	2027-02-03	Common Stock (5442)	Direct
2019-03-11	Stock Options NQ (Right to Buy)	$34.02	M	2344	Disposed	2025-02-06	Common Stock (2344)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64618	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.

F2: The price reported in Column 4 is the average price of $83.6989. The sold price range between $82.05 to $83.35. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is the average price of $83.6989. The sold price range between $83.36 to $84.12. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.